Tyrosine
- Half-Life (t½)
- PO: 1.5h
- Formula
- C9H11NO3
- Molecular Weight
- 181.19 g/mol
- Aliases
- Tyr, Y, L-Tyrosine
Pharmacological Mechanism
Catecholamine pathway: Tyr → L-DOPA (tyrosine hydroxylase, rate-limiting; see catecholamine synthesis) → dopamine (AADC) → norepinephrine (DβH) → epinephrine (PNMT). Also substrate for thyroid hormone (T3/T4 is iodinated tyrosine) and melanin (via tyrosinase). Phosphorylation site (tyrosine kinase family).
Half-Life & Elimination Curve (PO: 1.5h)
Plasma (PO)t½ Decay (1.5h)
- 0×t½0h100% (38.1 mg/L)
- 1×t½1.5h50% (19 mg/L)
- 2×t½3h25% (9.51 mg/L)
- 3×t½4.5h12.5% (4.76 mg/L)
- 4×t½6h6.3% (2.38 mg/L)
- 5×t½7.5h3.1% (1.19 mg/L)
Dosing Guidelines
Pharmacokinetic Parameters
- Oral (PO): Bioavailability (F): 90% · Volume of Distribution (Vd): 28 L · Absorption (ka): 1.5 h⁻¹ (t½ka ≈ 28m) [PMID 29168741]
Pathways It Modulates
Target Organ Systems
- Endocrine System
- Integumentary System
Interactions
- Levodopa (synergistic): Downstream of tyrosine via tyrosine hydroxylase (rate-limiting). L-DOPA bypasses the TH step.
- Dopamine (synergistic): Dietary precursor via tyrosine hydroxylase (rate-limiting).
Top Dietary Sources
Chemical Structure & Identifiers
- InChIKey: OUYCCCASQSFEME-QMMMGPOBSA-N
- SMILES: C1=CC(=CC=C1C[C@@H](C(=O)O)N)O
- Recon3D Metabolite ID: tyr__L
References